Treatment of Cryptococcal Meningitis with Combination Amphotericin B and Flucytosine for Four as Compared with Six Weeks
- 6 August 1987
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 317 (6), 334-341
- https://doi.org/10.1056/nejm198708063170602
Abstract
One hundred ninety-four patients with cryptococcal meningitis were enrolled in a multicenter, prospective, randomized clinical trial to compare the efficacy and toxicity of four as compared with six weeks of combination amphotericin B and flucytosine therapy. Among 91 patients who met preestablished criteria for randomization, cure or improvement was noted in 75 percent of those treated for four weeks and in 85 percent of those treated for six weeks. The estimated relapse rate for the four-week regimen was higher — 27 as compared with 16 percent — whereas the incidence of toxic effects for the two regimens was similar — 44 as compared with 43 percent. Among 23 transplant recipients, 4 of 5 treated for four weeks relapsed, leading to the decision to treat the rest of the group for six weeks. Only 3 of the 18 treated for six weeks relapsed. In a third group of 80 patients, the protocol was not followed during the initial four weeks, and these patients were not randomized. Thirty-eight died or relapsed. Multifactorial analysis of pretreatment factors for all 194 patients identified three significant predictors (P<0.05) of a favorable response: headache as a symptom, normal mental status, and a cerebrospinal fluid white-cell count above 20 per cubic millimeter.Keywords
This publication has 15 references indexed in Scilit:
- Cryptococcal Infection of the Central Nervous SystemMedical Clinics of North America, 1985
- “Proving the null hypothesis” in clinical trialsControlled Clinical Trials, 1982
- Cryptococcal meningitis: A review of 32 years experienceJournal of the Neurological Sciences, 1982
- Intracranial infection in cardiac transplant recipientsAnnals of Neurology, 1981
- A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal MeningitisThe New England Journal of Medicine, 1979
- Rapid determination of serum 5-fluorocytosine levels by high-performance liquid chromatographyAntimicrobial Agents and Chemotherapy, 1978
- Prognostic Factors in Cryptococcal MeningitisAnnals of Internal Medicine, 1974
- Pharmacokinetic Studies on the Oral Antimycotic Agent 5-Fluorocytosine in Individuals with Normal and Impaired Kidney FunctionChemotherapy, 1973
- Diagnosis of Cryptococcal MeningitisThe New England Journal of Medicine, 1971
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958